Home/Filings/4/0001209191-21-018655
4//SEC Filing

LIDGARD GRAHAM PETER 4

Accession 0001209191-21-018655

CIK 0001124140other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 5:48 PM ET

Size

6.7 KB

Accession

0001209191-21-018655

Insider Transaction Report

Form 4
Period: 2021-03-05
LIDGARD GRAHAM PETER
SVP, Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2021-03-05$121.33/sh11,735$1,423,80833,755 total
Holdings
  • Common Stock

    (indirect: By Trust)
    4,673
  • Common Stock

    (indirect: By 401(k))
    12,846
Footnotes (2)
  • [F1]The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]In addition to the shares of Common Stock reported on this Form 4, which total 51,274 shares, Mr. Lidgard also holds, in the aggregate, an additional 111,605 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001216274

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:48 PM ET
Size
6.7 KB